Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches

Acute myeloid leukemia (AML) is characterized by an increasing number of clonal myeloid blast cells which are incapable of differentiating into mature leukocytes. AML risk stratification is based on genetic background, which also serves as a means to identify the optimal treatment of individual pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowling, Paul, Tierney, Ciara, Dunphy, Katie, Miettinen, Juho J., Heckman, Caroline A., Bazou, Despina, O’Gorman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628952/
https://www.ncbi.nlm.nih.gov/pubmed/34842843
http://dx.doi.org/10.3390/proteomes9040042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628952/
https://www.ncbi.nlm.nih.gov/pubmed/34842843
http://dx.doi.org/10.3390/proteomes9040042

Ejemplares similares